Category stocks

Gossamer Bio Q1 Earnings Call Highlights

Key Points - Gossamer Bio is still targeting a September 2026 NDA submission for seralutinib in pulmonary arterial hypertension, with a June FDA pre-NDA meeting set to help shape the filing. Management said approval could potentially follow in the third quarter of 2027 if

Intel Falls 1% Ahead Of Earnings

Intel stock drops 1% in premarket trading Intel fell 1% in premarket trading after President Trump's comments. The decline comes as traders await Nvidia and retail earnings reports. Stock index futures also fell on Monday, indicating a cautious market tone.